Shunsuke Nakajima
Asahikawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Hepatocellular Carcinoma Arising Adjacent to Antiphospholipid Syndrome-associated Hepatic Infarction in a Non-cirrhotic Liver.
Journal: Internal medicine (Tokyo, Japan)
Published: March 25, 2025
Contrast-enhanced Ultrasonography Features for Diagnosing Pseudoprogression of Hepatocellular Carcinoma with Immunotherapy: A Case Report of the Response after Pseudoprogression.
Journal: Internal medicine (Tokyo, Japan)
Published: September 04, 2023
The effect of heat-killed Lactobacillus brevis SBL88 on improving selective hepatic insulin resistance in non-alcoholic fatty liver disease mice without altering the gut microbiota.
Journal: Journal of gastroenterology and hepatology
Published: February 04, 2023
A Successful Case of Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab with Multisystem Immune-related Adverse Events.
Journal: Internal medicine (Tokyo, Japan)
Published: May 01, 2022
Treatment of hepatocellular carcinoma with autologous platelets encapsulating sorafenib or lenvatinib: A novel therapy exploiting tumor-platelet interactions.
Journal: International journal of cancer
Published: August 11, 2021
Endoscopic findings of hepatocellular carcinoma invading the duodenum.
Journal: Japanese journal of clinical oncology
Published: May 20, 2021
Brain metastasis from hepatic cholangiolocellular carcinoma in a young female without chronic liver disease.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: July 21, 2020
Repeated Perforation of the Gallbladder in a Patient with Hepatocellular Carcinoma Receiving Lenvatinib.
Journal: Internal medicine (Tokyo, Japan)
Published: November 19, 2019
Long-term growth of intrahepatic papillary neoplasms: A case report.
Journal: World journal of gastroenterology
Published: July 17, 2019
Non-alcoholic fatty liver disease is a potential risk factor for liver injury caused by immune checkpoint inhibitor.
Journal: Journal of gastroenterology and hepatology
Published: June 05, 2019
Successful Treatment of Nivolumab-related Cholangitis with Prednisolone: A Case Report and Review of the Literature.
Journal: Internal medicine (Tokyo, Japan)
Published: February 26, 2019
Skeletal muscle mass is associated with toxicity, treatment tolerability, and additional or subsequent therapies in patients with hepatocellular carcinoma receiving sorafenib treatment.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: August 14, 2018
Last Updated: 09/26/2026